Wearable sensors could revolutionize monitoring of rare muscle disease
NCT ID NCT06153108
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study tests whether wearable sensors worn on the wrist and as a pendant can accurately track changes in arm and leg function in people with inclusion body myositis (IBM), a rare muscle disease that causes progressive weakness. Researchers aim to see if these sensors can provide a more objective and convenient way to monitor the disease at home compared to standard clinic exams. The study involves 20 participants who will wear the sensors during daily activities over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a simple, at-home way to track disease progression in inclusion body myositis, making clinical trials more efficient and reducing the need for frequent clinic visits.
- What could go wrong
- This is a small, early-stage study focused on validating the sensors, not testing a treatment. The sensors may not capture all aspects of the disease or may be inconvenient for some participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCLUSION BODY MYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can diet help manage a rare muscle disease? new study seeks answers
- Shocking muscles to move: new exercise hope for nerve disease patients
- New study tracks rare muscle disease without offering treatment
- Patients take the lead: rare myositis study puts your voice first
- Could a transplant drug help patients with rare muscle disease?
- New drug ABC008 shows promise in slowing rare muscle disease